Tags: Drug.
Lacosamide (INN formerly known as erlosamide harkeroside SPM 927 or ADD 234037) is a medication developed by Union Chimique Belge (UCB) for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat.The U.S. Food and Drug Administration (FDA) accepted UCB’s New Drug Application for lacosamide as of November 29 2007 beginning the approval process for the drug.
